1. Home
  2. CELU vs MBOT Comparison

CELU vs MBOT Comparison

Compare CELU & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
    SELLHOLDBUYas of a day ago
  • MBOT
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • CELU 2016
  • MBOT 2010
  • Country
  • CELU United States
  • MBOT United States
  • Employees
  • CELU N/A
  • MBOT N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • MBOT Medical/Dental Instruments
  • Sector
  • CELU Health Care
  • MBOT Health Care
  • Exchange
  • CELU Nasdaq
  • MBOT Nasdaq
  • Market Cap
  • CELU 42.2M
  • MBOT 50.4M
  • IPO Year
  • CELU N/A
  • MBOT N/A
  • Fundamental
  • Price
  • CELU $1.63
  • MBOT $1.70
  • Analyst Decision
  • CELU
  • MBOT Strong Buy
  • Analyst Count
  • CELU 0
  • MBOT 1
  • Target Price
  • CELU N/A
  • MBOT $9.00
  • AVG Volume (30 Days)
  • CELU 102.4K
  • MBOT 846.5K
  • Earning Date
  • CELU 12-06-2024
  • MBOT 05-14-2025
  • Dividend Yield
  • CELU N/A
  • MBOT N/A
  • EPS Growth
  • CELU N/A
  • MBOT N/A
  • EPS
  • CELU N/A
  • MBOT N/A
  • Revenue
  • CELU $48,200,000.00
  • MBOT N/A
  • Revenue This Year
  • CELU N/A
  • MBOT N/A
  • Revenue Next Year
  • CELU $233.89
  • MBOT N/A
  • P/E Ratio
  • CELU N/A
  • MBOT N/A
  • Revenue Growth
  • CELU 225.94
  • MBOT N/A
  • 52 Week Low
  • CELU $1.00
  • MBOT $0.82
  • 52 Week High
  • CELU $5.69
  • MBOT $3.38
  • Technical
  • Relative Strength Index (RSI)
  • CELU 46.69
  • MBOT 55.82
  • Support Level
  • CELU $1.64
  • MBOT $1.41
  • Resistance Level
  • CELU $2.40
  • MBOT $1.81
  • Average True Range (ATR)
  • CELU 0.20
  • MBOT 0.13
  • MACD
  • CELU 0.01
  • MBOT 0.01
  • Stochastic Oscillator
  • CELU 17.20
  • MBOT 72.50

Stock Price Comparison Chart: CELU vs MBOT

CELU
MBOT
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April012345678910111213CELU VS MBOT

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use